Stockscreener 앱 받기
292.60
3.51%
-10.63
Cencora Inc 주식(COR)의 최신 뉴스
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Published on: 2025-08-21 02:56:19 - classian.co.kr
Cencora directors ink $111M deal related to opioid claims - MSN
Cencora Inc. Rebound Backed by Sentiment ShiftWeekly Market Report & Safe Investment Capital Preservation Plans - kangso.co.kr
Cencora Posts Modest 1.5 Gain as Volume Plunge Sends Stock to 405th Trading Rank Amid Sector Restructuring Focus - AInvest
What makes Cencora Inc. stock price move sharplyJuly 2025 Reactions & Verified Entry Point Signals - newsyoung.net
Cencora directors settle opioid claims for $111M - AInvest
Cencora directors ink $111M opioid deal (COR:NYSE) - Seeking Alpha
Cencora Shares Dip 0.70% as $320M Volume Ranks 332nd Amid Strategic Shifts and Sector Volatility - AInvest
$111.25M Del. Settlement Proposed For Cencora Opioid Suits - Law360
Cencora Directors Settle Opioid Claims for $111 Million - AInvest
Cencora Directors Reach $111 Million Deal on Opioid Claims - Bloomberg.com
Why Cencora (COR) is a Top Value Stock for the Long-Term - Yahoo Finance
Cencora’s 1.32% Rally Amid 295th-Ranked $350M Volume as Industry Navigates Regulatory Shifts and Profit Volatility - AInvest
Cencora Inc. Tests 50 Day MA After Sharp DeclineWeekly Stock Analysis & Stock Portfolio Risk Control - newsyoung.net
Will Cencora Inc. stock go up in YEARMarket Performance Report & Community Verified Watchlist Alerts - newsimpact.co.kr
Short Term Trend Reversal in Cencora Inc. PossibleJuly 2025 Catalysts & High Accuracy Buy Signal Tips - thegnnews.com
Cencora (COR) Stock Surpasses Market Gains with Strong PerformanceNews and Statistics - IndexBox
Ex-Dividend Reminder: Cencora, Organon and Esquire Financial Holdings - Nasdaq
Cencora Stock: Analyst Estimates & Ratings - Yahoo Finance
Wells Fargo raises Cencora stock price target to $354 on strong U.S. Healthcare performance - Investing.com
Cencora price target raised to $354 from $337 at Wells Fargo - TipRanks
Stock Analysis | Cencora OutlookMixed Signals as Technicals and Analysts Diverge - AInvest
Cencora Plummets 0.53% Amid Regulatory Scrutiny Ranks 189th in $580M Trading Volume Despite Sector Resilience - AInvest
Investors Still Waiting For A Pull Back In Cencora, Inc. (NYSE:COR) - 富途牛牛
Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap (NYSE:COR) - Seeking Alpha
Cencora (COR) Plummets 2.44% Amid Volatile Intraday Move: What’s Fueling the Selloff? - AInvest
Cencora Lifts Earnings Outlook After Strong Q3 Performance - MSN
Cencora & The Lash Group Settle Data Breach Litigation for $40 Million - The HIPAA Journal
Cencora (COR) Shares Jump 1.95% as Trading Volume Surges to $530M Ranking 184th in Market Activity - AInvest
3 Reasons Growth Investors Will Love Cencora (COR) - Yahoo Finance
RSI Suggests Rebound May Be Near in Cencora Inc.Top Gaining Picks With Entry Signals Identified - beatles.ru
Is It Smart To Buy Cencora, Inc. (NYSE:COR) Before It Goes Ex-Dividend? - simplywall.st
Why You Might Be Interested In Cencora, Inc. (NYSE:COR) For Its Upcoming Dividend - ca.finance.yahoo.com
Published on: 2025-08-10 00:34:30 - metal.it
Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Cencora Rises 2.42% as Trading Volume Slumps to 313th Market Rank - AInvest
Cencora Q3: Growing Specialty Drug Distributions; Initiate At Buy (NYSE:COR) - Seeking Alpha
Research Alert: CFRA Raises View On Shares Of Cencora, Inc. To Buy From Hold - 富途牛牛
Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results? - MSN
Cencora, Inc. Reports Strong Q3 2025 Financial Results - The Globe and Mail
Cencora Reports Strong Q3 2025 Financial Results - The Globe and Mail
Cencora: Fiscal Q3 Earnings Snapshot - New Haven Register
Cencora (COR) Reports Q3 Earnings Growth, Maintains US$0.55 Dividend - simplywall.st
Cencora’s Earnings Call: Strong Growth Amid Challenges - TipRanks
Cencora Earnings: Solid Results Illustrate Healthy Demand and Stable Outlook; Shares Fairly Valued - Morningstar
Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook - AOL.com
Cencora Benefits From Strong GLP-1 Sales, Healthy Utilization Trends, and Growing Specialty Assets - Morningstar
Cencora, Inc. SEC 10-Q Report - TradingView
Cencora raises 2025 EPS guidance to $15.85–$16 and narrows outlook as specialty drives growth - MSN
Cencora weakness after earnings ‘overdone,’ says Leerink - TipRanks
COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised - The Globe and Mail
Earnings call transcript: Cencora Inc. beats Q3 2025 expectations, stock dips - Investing.com Nigeria
Transcript : Cencora, Inc., Q3 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
2.29%
2.04%
자본화:
|
볼륨(24시간):